Switzerland Expands Public Health Coverage: Vaccines and Cancer Screening Now Fully Covered

Switzerland has announced a significant expansion of its public health coverage, marking a major step forward in preventive healthcare accessibility. The Federal Council has unveiled comprehensive changes that will eliminate insurance excess charges for key vaccines and extend cancer screening coverage, set to take effect from January 2026. This landmark decision represents Switzerland's commitment to enhancing preventive healthcare measures and ensuring broader access to essential medical services for its residents.

Starting January 1st, 2026, Switzerland will implement a groundbreaking policy that exempts several crucial vaccines from insurance excess charges. The Federal Office of Public Health has confirmed coverage for vaccines against diphtheria, tetanus, covid-19, mpox, pneumococcus, and meningococcus. While the standard 10% co-payment requirement remains in place, the removal of excess charges significantly reduces the financial burden on patients. In a notable addition to maternal healthcare, the policy includes coverage for RSV vaccination for pregnant women, ensuring protection for newborns from birth.

The reform includes a significant expansion of colorectal cancer screening coverage, extending the age limit from 69 to 75 years, effective July 1st, 2025. This decision is supported by compelling statistics showing that approximately half of all colorectal cancer cases are diagnosed after age 70. The screening program will be implemented across all cantons, though specific testing protocols and frequencies may vary by region. This extension of coverage reflects Switzerland's data-driven approach to public health policy and its commitment to early cancer detection in vulnerable age groups.

The implementation of these new healthcare policies demonstrates Switzerland's systematic approach to improving public health outcomes. Beyond vaccine and cancer screening coverage, the reforms also include measures to reduce bureaucratic burden for chronically ill patients, who will no longer need annual justification for medical aids and devices reimbursement. These changes are expected to increase preventive care participation rates and improve early detection of serious health conditions across the Swiss population. The canton-based healthcare system will maintain its regional administration while ensuring uniform access to these expanded benefits.